GEFFKEN DANIEL E. (Chief Financial Officer) purchased 50K shares of ELOXX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $36.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/1/2021ACC: 0001415889-21-005600
Officer· Chief Financial Officer
Since Apr 2021
+50K
Net shares
Net buyer
$36.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
$0.72
Trade value
$36K
% of position
New position
11/29/2021
0.00→50K
Total
Net shares
+50K
Net value
$36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/29/2021 | P · Purchase | +50K | $0.72 | $36K | New position | 0.00 | 50K |
| Total | +50K | $36K | ||||||
Derivative Transactions0
No derivative transactions reported